Company Profile

Elate Medical Inc
Profile last edited on: 11/16/23      CAGE: 99Y11      UEI: DRJ8QXK6F685

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
2020
First Award
2022
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

828 Sherry Drive
Valley Cottage, NY 10989
   (212) 873-7375
   moonsoomjin@gmail.com
   elate-medical.com
Location: Single
Congr. District: 17
County: Rockland

Public Profile

Aa a team, the personnel associated with Elate Meidcal Inc reprot having expertise and experience in a number of areas of Specialty. Contractual (1) Manufacturing Service: a network of GMP facilities at leading academic institutions and hospitals that provide time and cost-efficient service for early phase cell therapy products for the firm's clients. (2) Developing CMC for Cell Therapy - in-depth expertise in devleloping an automated, robust manufacturing process, and documentation for IND CMC; Clinical care and studies with Cell therapy products - leading experts in developing CAR T cells, virus-specific T cells, and other cellular products in providing clinical care and studies to treat patients with cancer and infectious diseases. Manufacturing platforms with Turnkey solution: developing 00% automated, walk-away operation at point-of-care device for manufacturing cell therapy drugs.- device is designed to be customizable for client specific manufacturing process

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 1 NIH $400,000
Project Title: Advanced Manufacturing to Speed Availability of Emerging Autologous Cell-Based Therapies

Key People / Management

  Moonsoo Jin -- Founder and CEO

  Josh Boutin

  Michael Hsu

  Shahin Rafii

  Mark Stasiak

  Koen Van Besien

Company News

There are no news available.